BST.MC Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: December 03, 2025
Report Source: 2025 2nd Quarter Report
Biotechnology Assets SA. Stock Analysis BST.MC
Biotechnology Assets SA operates as a biopharmaceutical company. The company is headquartered in Jerez De La Frontera, Cadiz and currently employs 30 full-time employees. The company went IPO on 2011-06-14. The firm's main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The firm's purpose is the acquisition and promotion of real estate of an urban nature for lease through the ownership of assets directly, through companies with this purpose, with the holding of shares in the capital of other entities, resident or not in the Spanish territory, or through collective investment vehicles.
Read More Biotechnology Assets SA (BST.MC) Chart
Key Statistics of Biotechnology Assets SA (BST.MC)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
€0.27Volume
120.58KP/E Ratio (TTM)
-52 Week Range
Market Cap
16.62MAvg. Volume
250.91KDividend Yield
-Financial Metrics & Statements of Biotechnology Assets SA (BST.MC)
FAQ's for Biotechnology Assets SA (BST.MC)
- According to Musaffa’s Shariah screening methodology, Biotechnology Assets SA (BST.MC) is currently classified as HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.